# Profiling the Intratumoral Microbiome of Pancreatic Ductal Adenocarcinoma Based on EUS-FNB Tissue Samples and Exploring Its Impact on Tumor Diagnosis and Prognosis.

> **NCT06655233** · — · RECRUITING · sponsor: **The Third Xiangya Hospital of Central South University** · enrollment: 50 (estimated)

## Conditions studied

- Pancreatic Cancer
- EUS-FNB
- Intratumoral Microbiota
- Diagnosis
- Prognosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06655233
- **Lead sponsor:** The Third Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-01
- **Primary completion:** 2025-12-30
- **Final completion:** 2026-05-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06655233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06655233, "Profiling the Intratumoral Microbiome of Pancreatic Ductal Adenocarcinoma Based on EUS-FNB Tissue Samples and Exploring Its Impact on Tumor Diagnosis and Prognosis.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06655233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*